Adjuvant pertuzumab (PER) for HER2-positive early stage breast cancer (eBC): A Swiss experience
Details
Serval ID
serval:BIB_7F2F9C828B3A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Adjuvant pertuzumab (PER) for HER2-positive early stage breast cancer (eBC): A Swiss experience
Journal
European Journal of Cancer
ISSN
0959-8049
Publication state
Published
Issued date
04/2018
Volume
92
Pages
S93
Language
english
Keywords
Cancer Research, Oncology
Create date
19/09/2021 20:31
Last modification date
20/09/2021 5:41